Nasdaq

Verrica Pharmaceuticals Receives Milestone Payments and Initiates Global Phase 3 Trial for YCANTH® Treatment of Common Warts

Verrica is set to receive an accelerated $8 million milestone payment for the initiation of a global Phase 3 clinical trial, providing non-dilutive capital sooner than anticipated. Securing a $10 ...
Morningstar

Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim

PRINCETON, N.J., Sept. 22, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company advancing medicines that modulate the melanocortin receptor system, today ...
Morningstar

PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.

TOKYO, Nov. 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM") announces that today, PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka; President and COO: Toichi Takino; hereinafter ...